Science

415 Capital is a specialist venture capital firm dedicated to investing in breakthrough and life-saving medical innovation. For over 30 years, the team has empowered exceptional entrepreneurs through capital, expertise, and market access, focusing on large unmet patient needs in chronic diseases, particularly cardio & neurovascular disorders.

5AM Ventures is a leading life science venture capital firm focused on funding and building next-generation life sciences companies. They primarily invest in early-stage private therapeutic companies, with an emphasis on Series A, and also invest in small and mid-cap public and later-stage private biotech and life science companies.

6 Dimensions Capital is a leading global healthcare investment firm focusing on investments in healthcare startups or growth-stage companies with operations in the U.S., Europe, China, Israel and other countries. The firm helps entrepreneurs create and grow innovative healthcare businesses for the benefit of patients worldwide.

8VC is a technology and life sciences investment firm that builds and invests in the world’s most ambitious companies. They partner with leading entrepreneurs and innovators to build technology platforms that create lasting economic and societal value.

The corporate venture arm of AbbVie, investing in novel, transformational therapeutics at discovery and preclinical stages.

Adjuvant Capital is a life sciences investment fund that backs ambitious companies developing drugs, vaccines, diagnostics, medical devices, and other technologies to address critical global public health challenges. It focuses on historically overlooked market segments, leveraging expertise to translate opportunities into social and financial returns. The firm's investment model is heavily influenced by global trends such as climate change and antimicrobial resistance.

AlbionVC is the technology investment arm of Albion Capital Group LLP. They support visionary founders with long-term capital and scale-up expertise, investing from seed through to Series B in high-growth companies, predominantly in the UK.

Alta Partners is a leading healthcare and life sciences venture capital firm, helping entrepreneurs build high-impact companies since 1996. Their focus is on building small, focused portfolios and dedicating significant time to each investment. They aim to make a positive impact in healthcare.

Altitude Life Science Ventures is a venture capital firm investing in early-stage life science companies. They focus on markets with strong demand and growth potential, and then back the highest-quality entrepreneurs.

aMoon is a global HealthTech and Life Sciences investment fund based in Israel. They partner with entrepreneurs using science and technology to transform healthcare, accelerating the development of revolutionary ideas.

Ankur Capital is an early-stage venture capital firm investing in digital and deep science technologies to create impact. They focus on entrepreneurs building breakthroughs for a better world, particularly in overlooked markets. They provide capital and extensive support to founders.

Anzu Partners is an investment firm focusing on industrial and life science technology companies with transformative potential. They provide capital and expertise in business development, market positioning, and operations to help entrepreneurs commercialize innovations. Anzu manages approximately $1 billion in assets across various funds.